世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000031921

世界のパーキンソン病治療市場規模調査:薬剤クラス別、流通チャネル別、患者ケア環境別、地域別の予測(2022年〜2028年)

Bizwit Research & Consulting LLP

Global Parkinson’s Disease Treatment Market Size study, By Drug Class (Levodopa/carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-inhibitors, Anticholinergics, Other Drugs), By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies), By Patient Care Setting (Hospitals, Clinics), and Regional Forecasts 2022-2028

発刊日 2022/03/02

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000031921

Single
Enterprisewide

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

パーキンソン病は、脳の神経細胞が障害され、ドーパミン濃度が低下し、動作に影響を及ぼす中枢神経系の疾患で、しばしば震え、硬直、徐脈、姿勢の乱れなどを共通の症状として含んでいます。パーキンソン病の有病率の上昇、老年人口の増加、研究開発活動に対する政府の資金提供の増加などが、世界中で市場の需要を急増させる主な要因となっています。例えば、パーキンソン財団によると、米国では2020年に約100万人がパーキンソン病(PD)に罹患し、これは多発性硬化症、筋ジストロフィー、ルー・ゲーリッグ病(または筋萎縮性側索硬化症)と診断された人口の合計を上回り、2030年末には120万人に達すると予測されています。しかし、代替治療法の利用が可能であることが、2022年から2028年の予測期間における市場の成長を阻害しています。また、ブランド薬の特許切れや強力な医薬品パイプラインは、予測期間中の市場需要の触媒として作用すると予想されます。

パーキンソン病治療の世界市場調査において考慮した主要地域には、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域が含まれます。北アメリカは、整備された医療インフラの存在と、本疾患の有病率の増加により、市場シェアの面で世界の主要地域となっています。一方、アジア太平洋地域は、2022年から2028年の予測期間において、最も高いCAGRを示すと予想されています。研究開発活動の増加や政府の支援政策などの要因が、アジア太平洋地域のパーキンソン病治療市場に有利な成長見通しを生み出すと考えられます。

主要企業

  • GlaxoSmithKline plc.
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH.
  • Impax Laboratories LLC
  • AbbVie Inc.
  • Bausch Health
  • Lundbeck
  • Sun Pharmaceutical Industries Ltd.
  • ACADIA Pharmaceuticals Inc.
  • Merck & Co. Inc.

この調査の目的は、近年のさまざまなセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品内容の詳細な分析とともに、利害関係者が投資できるミクロ市場での機会についても報告します。

セグメント・サブセグメント

➣ 薬剤クラス別
  ◇ レボドパ/カルビドパ
  ◇ ドーパミン受容体作動薬
  ◇ MAO阻害薬
  ◇ COMT阻害薬
  ◇ 抗コリン作用薬
  ◇ その他の薬剤
➣ 流通チャネル別
  ◇ 病院薬局
  ◇ 小売薬局
  ◇ オンライン薬局
➣ 患者ケア環境別
  ◇ 病院
  ◇ クリニック
  • 地域別
    ➣ 北アメリカ
      ◇ アメリカ
      ◇ カナダ
    ➣ ヨーロッパ
      ◇ イギリス
      ◇ ドイツ
      ◇ フランス
      ◇ スペイン
      ◇ イタリア
      ◇ その他のヨーロッパ
    ➣ アジア太平洋地域
      ◇ 中国
      ◇ インド
      ◇ 日本
      ◇ オーストラリア
      ◇ 韓国
      ◇ その他のAPAC
    ➣ ラテンアメリカ
      ◇ ブラジル
      ◇ メキシコ
    ➣ 世界のその他の地域

調査対象年

  • 実績データ - 2018年、2019年、2020年
  • 基準年 - 2021年
  • 予測期間 - 2022年から2028年

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Parkinson’s Disease Treatment Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Parkinson’s Disease Treatment Market, by Drug Class, 2020-2028 (USD Billion)
1.2.3. Global Parkinson’s Disease Treatment Market, by Distribution Channel, 2020-2028 (USD Billion)
1.2.4. Global Parkinson’s Disease Treatment Market, by Patient Care Setting, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Parkinson’s Disease Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Parkinson’s Disease Treatment Market Dynamics
3.1. Parkinson’s Disease Treatment Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growth in ageing population and the increase in the prevalence of Parkinson’s disease
3.1.1.2. Increasing government funding for research and development
3.1.2. Market Challenges
3.1.2.1. Availability of alternative treatments
3.1.3. Market Opportunities
3.1.3.1. Patent expiry of branded drugs
3.1.3.2. Strong drug pipeline

Chapter 4. Global Parkinson’s Disease Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Parkinson’s Disease Treatment Market, by Drug Class
6.1. Market Snapshot
6.2. Global Parkinson’s Disease Treatment Market by Drug Class, Performance - Potential Analysis
6.3. Global Parkinson’s Disease Treatment Market Estimates & Forecasts by Drug Class 2019-2028 (USD Billion)
6.4. Parkinson’s Disease Treatment Market, Sub Segment Analysis
6.4.1. Levodopa/carbidopa
6.4.2. Dopamine Receptor Agonists
6.4.3. MAO-Inhibitors
6.4.4. COMT-inhibitors
6.4.5. Anticholinergics
6.4.6. Other Drugs

Chapter 7. Global Parkinson’s Disease Treatment Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Parkinson’s Disease Treatment Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Parkinson’s Disease Treatment Market Estimates & Forecasts by Distribution Channel 2019-2028 (USD Billion)
7.4. Parkinson’s Disease Treatment Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Retailer Pharmacies
7.4.3. Online Pharmacies

Chapter 8. Global Parkinson’s Disease Treatment Market, by Patient Care Setting
8.1. Market Snapshot
8.2. Global Parkinson’s Disease Treatment Market by Patient Care Setting, Performance - Potential Analysis
8.3. Global Parkinson’s Disease Treatment Market Estimates & Forecasts by Patient Care Setting 2019-2028 (USD Billion)
8.4. Parkinson’s Disease Treatment Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Clinics

Chapter 9. Global Parkinson’s Disease Treatment Market, Regional Analysis
9.1. Parkinson’s Disease Treatment Market, Regional Market Snapshot
9.2. North America Parkinson’s Disease Treatment Market
9.2.1. U.S. Parkinson’s Disease Treatment Market
9.2.1.1. Drug Class estimates & forecasts, 2019-2028
9.2.1.2. Distribution Channel estimates & forecasts, 2019-2028
9.2.1.3. Patient Care Setting estimates & forecasts, 2019-2028
9.2.2. Canada Parkinson’s Disease Treatment Market
9.3. Europe Parkinson’s Disease Treatment Market Snapshot
9.3.1. U.K. Parkinson’s Disease Treatment Market
9.3.2. Germany Parkinson’s Disease Treatment Market
9.3.3. France Parkinson’s Disease Treatment Market
9.3.4. Spain Parkinson’s Disease Treatment Market
9.3.5. Italy Parkinson’s Disease Treatment Market
9.3.6. Rest of Europe Parkinson’s Disease Treatment Market
9.4. Asia-Pacific Parkinson’s Disease Treatment Market Snapshot
9.4.1. China Parkinson’s Disease Treatment Market
9.4.2. India Parkinson’s Disease Treatment Market
9.4.3. Japan Parkinson’s Disease Treatment Market
9.4.4. Australia Parkinson’s Disease Treatment Market
9.4.5. South Korea Parkinson’s Disease Treatment Market
9.4.6. Rest of Asia Pacific Parkinson’s Disease Treatment Market
9.5. Latin America Parkinson’s Disease Treatment Market Snapshot
9.5.1. Brazil Parkinson’s Disease Treatment Market
9.5.2. Mexico Parkinson’s Disease Treatment Market
9.6. Rest of The World Parkinson’s Disease Treatment Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. GlaxoSmithKline plc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Teva Pharmaceutical Industries Ltd.
10.2.3. Boehringer Ingelheim International GmbH.
10.2.4. Impax Laboratories LLC
10.2.5. AbbVie Inc.
10.2.6. Bausch Health.
10.2.7. Lundbeck
10.2.8. Sun Pharmaceutical Industries Ltd.
10.2.9. ACADIA Pharmaceuticals Inc.
10.2.10. Merck & Co. Inc.

Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

List of Tables
TABLE 1. Global Parkinson’s Disease Treatment Market, report scope
TABLE 2. Global Parkinson’s Disease Treatment Market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Parkinson’s Disease Treatment Market estimates & forecasts by Drug Class 2019-2028 (USD Billion)
TABLE 4. Global Parkinson’s Disease Treatment Market estimates & forecasts by Distribution Channel 2019-2028 (USD Billion)
TABLE 5. Global Parkinson’s Disease Treatment Market estimates & forecasts by Patient Care Setting 2019-2028 (USD Billion)
TABLE 6. Global Parkinson’s Disease Treatment Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 7. Global Parkinson’s Disease Treatment Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Parkinson’s Disease Treatment Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Parkinson’s Disease Treatment Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Parkinson’s Disease Treatment Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Parkinson’s Disease Treatment Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Parkinson’s Disease Treatment Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Parkinson’s Disease Treatment Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Parkinson’s Disease Treatment Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. Global Parkinson’s Disease Treatment Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. U.S. Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 17. U.S. Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 18. U.S. Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 19. Canada Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 20. Canada Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 21. Canada Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 22. UK Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 23. UK Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 24. UK Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 25. Germany Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 26. Germany Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 27. Germany Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 28. RoE Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 29. RoE Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 30. RoE Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 31. China Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 32. China Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 33. China Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 34. India Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 35. India Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 36. India Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 37. Japan Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 38. Japan Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 39. Japan Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 40. RoAPAC Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 41. RoAPAC Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 42. RoAPAC Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 43. Brazil Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 44. Brazil Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 45. Brazil Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 46. Mexico Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 47. Mexico Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 48. Mexico Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 49. RoLA Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 50. RoLA Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 51. RoLA Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 52. Row Parkinson’s Disease Treatment Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 53. Row Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 54. Row Parkinson’s Disease Treatment Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Parkinson’s Disease Treatment Market
TABLE 56. List of primary sources, used in the study of global Parkinson’s Disease Treatment Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered

List of figures
FIG 1. Global Parkinson’s Disease Treatment Market, research methodology
FIG 2. Global Parkinson’s Disease Treatment Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Parkinson’s Disease Treatment Market, key trends 2021
FIG 5. Global Parkinson’s Disease Treatment Market, growth prospects 2022-2028
FIG 6. Global Parkinson’s Disease Treatment Market, porters 5 force model
FIG 7. Global Parkinson’s Disease Treatment Market, pest analysis
FIG 8. Global Parkinson’s Disease Treatment Market, value chain analysis
FIG 9. Global Parkinson’s Disease Treatment Market by segment, 2019 & 2028 (USD Billion)
FIG 10. Global Parkinson’s Disease Treatment Market by segment, 2019 & 2028 (USD Billion)
FIG 11. Global Parkinson’s Disease Treatment Market by segment, 2019 & 2028 (USD Billion)
FIG 12. Global Parkinson’s Disease Treatment Market by segment, 2019 & 2028 (USD Billion)
FIG 13. Global Parkinson’s Disease Treatment Market by segment, 2019 & 2028 (USD Billion)
FIG 14. Global Parkinson’s Disease Treatment Market, regional snapshot 2019 & 2028
FIG 15. North America Parkinson’s Disease Treatment Market 2019 & 2028 (USD Billion)
FIG 16. Europe Parkinson’s Disease Treatment Market 2019 & 2028 (USD Billion)
FIG 17. Asia pacific market 2019 & 2028 (USD Billion)
FIG 18. Latin America Parkinson’s Disease Treatment Market 2019 & 2028 (USD Billion)
FIG 19. Global Parkinson’s Disease Treatment Market, company market share analysis (2021)

この商品のレポートナンバー

0000031921

TOP